20% off during October with code SRP2020% OFF DURING OCTOBER
SRP Peptide Pre-Workout frontSRP Peptide Pre-Workout back
COMING SOONPEPTIDE PRE-WORKOUTPRE-ORDER
Free GHK-Cu 100 mg vial with every order through October 11. Click for details. FREE 100 MG VIAL WITH EVERY ORDERSee gift details →
Wolverine Blend BPC-157 and TB-500 research pathways, evidence limitations, and safety chart. HOW WOLVERINE BLEND WORKS Explore Wolverine Blend →
Items in shopping cart:
SRP RESEARCH PULSE

Products are color coded by category

SRP GHK-Cu 100 mg research vial, complimentary with every order through October 11

YOUR OCTOBER GIFT

Free GHK-Cu 100 mg vial with every order through October 11

One complimentary vial is added automatically when you add a paid item to your cart. Your gift appears as FREE at checkout. No gift code is needed.

Free gift with every order, plus 20% off. Use code SRP20 for the October discount. Visit SRP20.com for Halloween savings →

Ends October 11, 2026, at 11:59 PM Eastern. One gift per order. Laboratory research only. Not for human use.

Continue to shop →
← Return to the Research Vault

Hormone signaling · Compound guide

GHK-Cu

Explore the mechanisms, study findings and evidence limits behind this research topic.

Product artwork identifies the SRP listing. It does not demonstrate safety or clinical benefit. The evidence guide and its sources follow below.

View product label and documentation →
GHK-Cu Research Vials
COPPER PEPTIDE RESEARCH • TIER 1

GHK-Cu Research Guide

An evidence-mapped guide to the copper-binding tripeptide GHK-Cu, including extracellular-matrix research, delivery studies, evidence gaps, and route-specific safety concerns.

Laboratory Research Only: Educational information—not medical advice. SRP material is not intended for human consumption, diagnosis, treatment, or prevention of disease.
IdentityGlycyl-L-histidyl-L-lysine copper complex
Primary research areasMatrix remodeling, fibroblasts, skin and wound models
Evidence baseMostly cell, formulation, and animal research
Regulatory statusNo FDA-approved injectable GHK-Cu drug

Fast Answer

GHK-Cu is a naturally occurring copper-binding tripeptide complex studied for its interactions with fibroblasts, collagen production, extracellular-matrix remodeling, and tissue-repair models. Much of the literature is preclinical or formulation-focused.

Topical cosmetic discussion should not be treated as evidence for injectable use. Route, formulation, purity, and exposure can materially change both biological behavior and safety questions.

Proposed Biological Roles

GHK contains the amino acids glycine, histidine, and lysine and can coordinate copper ions. Laboratory studies have reported effects on collagen synthesis and on matrix metalloproteinase and tissue-inhibitor expression in cultured fibroblasts.

These observations support investigation of matrix turnover rather than a simple “more collagen” claim. Healthy tissue remodeling requires regulated synthesis and breakdown, and cell-culture findings do not prove a cosmetic or therapeutic outcome in people.

Evidence Map

  • Cell research: fibroblast studies report changes in collagen and MMP-2-related pathways.
  • Delivery research: microneedle and hydrogel studies explore permeability and localized delivery.
  • Animal models: biomaterial studies report wound-closure, angiogenesis, and remodeling signals.
  • Human evidence: limited for many promoted claims, especially systemic or injectable use.

Safety and Interpretation Limits

FDA states that compounded injectable GHK-Cu may present immunogenicity risks related to aggregation and peptide impurities and that human safety information is limited. That caution is route-specific and should not be blurred with topical cosmetic research.

SRP material is for laboratory research only. This page does not establish clinical effectiveness, personal suitability, injection safety, or an anti-aging indication.

Frequently Asked Questions

Is GHK-Cu the same as copper metal?

No. GHK-Cu is a peptide complex that coordinates a copper ion; its biological and chemical behavior depends on the complex and formulation.

Is most GHK-Cu evidence clinical?

No. Much of the cited evidence comes from cells, animal models, and delivery-formulation studies.

Can topical findings be applied to injection?

No. Route-specific exposure and safety questions make that extrapolation unreliable.

Primary and Official Sources

  1. 01GHK-Cu and MMP-2 expression in fibroblasts
  2. 02GHK-Cu and collagen synthesis
  3. 03FDA compounding safety-risk table
Scroll to Top
View Cart